CDKN2A and cancer: A similar result was obtained for p53 staining in the case reported by Ates D et al. (2024) with FIGO IVA stage but with negative p16 staining [23], proving that this type of cancer must be further studied to unravel all its molecular changes to be able to better establish the prognosis.